🇺🇸 FDA
Patent

US 8969292

High affinity leptins and leptin antagonists

granted A61KA61K31/05A61K31/575

Quick answer

US patent 8969292 (High affinity leptins and leptin antagonists) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
Grant date
Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/05, A61K31/575, A61K38/22, A61K38/2264